<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Dr. Moon-joo Kim on Medium]]></title>
        <description><![CDATA[Stories by Dr. Moon-joo Kim on Medium]]></description>
        <link>https://medium.com/@itomatokids?source=rss-0daf706e906c------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*M6iliZq6RHxMxWwMRC69Dg.jpeg</url>
            <title>Stories by Dr. Moon-joo Kim on Medium</title>
            <link>https://medium.com/@itomatokids?source=rss-0daf706e906c------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sun, 22 Nov 2026 19:12:19 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@itomatokids/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Why Is Autism Increasing? Could Modern Sugar Consumption Hold a Key Clue?]]></title>
            <link>https://medium.com/@itomatokids/why-is-autism-increasing-could-modern-sugar-consumption-hold-a-key-clue-d457bee4b689?source=rss-0daf706e906c------2</link>
            <guid isPermaLink="false">https://medium.com/p/d457bee4b689</guid>
            <category><![CDATA[asd]]></category>
            <category><![CDATA[autism-treatment]]></category>
            <category><![CDATA[autism-spectrum-disorder]]></category>
            <category><![CDATA[asperger]]></category>
            <category><![CDATA[autism]]></category>
            <dc:creator><![CDATA[Dr. Moon-joo Kim]]></dc:creator>
            <pubDate>Tue, 15 Sep 2026 06:29:38 GMT</pubDate>
            <atom:updated>2026-09-15T06:29:38.627Z</atom:updated>
            <content:encoded><![CDATA[<p>- From maternal diabetes to the critical 20-month window of autistic regression. -</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*dUi62_yYSJZi0VlfhEloTw.png" /></figure><p>One of the most dramatic shifts in modern human history is how sugar transformed from a rare luxury into an everyday staple. Over the past century, refined carbohydrates, sugar-sweetened beverages, and high-fructose corn syrup (HFCS) became deeply embedded in our food supply. Concurrently, rates of obesity, type 2 diabetes, and gestational diabetes mellitus (GDM) soared — alongside a rapid rise in Autism Spectrum Disorder (ASD) diagnoses.</p><p>Are these parallel trends purely coincidental?</p><p>While current scientific evidence cannot justify claiming that sugar directly causes autism, extensive epidemiological literature demonstrates a clear link: <strong>excessive sugar intake drives metabolic dysfunction, and maternal metabolic disruption consistently correlates with an increased risk of ASD in offspring.</strong></p><p>The critical question is not whether a single ingredient is “toxic,” but whether post-industrial shifts in sugar consumption have fundamentally altered the metabolic environment from pregnancy through early childhood — impacting neurodevelopment in genetically vulnerable children.</p><h3>The Maternal Signal: Gestational Metabolic Health and Fetal Brain Development</h3><p>A massive 2025 systematic review published in <em>The Lancet Diabetes &amp;Endocrinology</em> — analyzing 202 observational studies and 56.1 million pregnancies — found that maternal diabetes during pregnancy was associated with a <strong>25% increased risk of ASD</strong> in offspring, as well as elevated risks for ADHD and intellectual disability.</p><p>Timing appears to be everything. A large-scale <em>JAMA</em> study of over 322,000 births observed that gestational diabetes diagnosed <strong>before 26 weeks</strong> was significantly associated with higher ASD risk (adjusted hazard ratio = 1.42), whereas diagnoses made after 26 weeks showed no such clear association.</p><p>• Early-onset GDM (&lt;26 weeks): Statistically significant increase in ASD risk<br>• Late-onset GDM (&gt;26 weeks): No clear signal</p><p>This timing signal suggests that exposure to maternal hyperglycemia during early, sensitive windows of fetal brain development matters far more than a binary diagnosis late in pregnancy. Elevated maternal blood sugar triggers a cascade of systemic inflammation, oxidative stress, and altered fetal gene regulation during peak neural formation.</p><h3>Fructose, the Gut Microbiome, and Immune Pathways</h3><p>When examining sugars, fructose warrants specific attention. Unlike glucose, fructose does not cause sharp spikes in blood glucose or insulin. A simplistic “fructose $\rightarrow$ blood sugar spike $\rightarrow$ ASD” model is physiologically incorrect.</p><p>However, fructose is metabolized primarily in the liver and intestines. Recent preclinical studies show that high fructose exposure can alter the gut microbiota composition, thin the protective colonic mucus layer, and increase intestinal barrier permeability (“leaky gut”). This disruption allows bacterial toxins to cross the gut lining, triggering systemic low-grade inflammation.</p><p>In autism research, the <strong>gut–immune–brain axis</strong> has become a central focus. How early-life fructose exposure alters gut barrier function and systemic inflammation in metabolically vulnerable children is a vital area of ongoing clinical study.</p><h3>The 20-Month Convergence: Dietary Transitions and Autistic Regression</h3><p>In clinical practice, parents frequently describe a startling pattern: typical early development followed by a loss of speech and social engagement around 18 to 20 months.</p><p>A comprehensive meta-analysis of 97 studies confirmed that approximately <strong>30% of children with ASD experience skill regression</strong>, with a mean onset age of <strong>19.8 months</strong>.</p><p>Interestingly, this exact developmental window coincides with a radical dietary shift:</p><p><strong>Infants (6–11 months):</strong> ~60.6% consume added sugars.</p><p><strong>Toddlers (12–23 months):98.3%</strong> consume added sugars, with intake shifting heavily toward sweetened drinks, baked goods, and ultra-processed snacks.</p><p>This temporal overlap — where average autistic regression peaks at ~20 months just as children transition to adult-style high-sugar diets — does not prove direct causation. However, it raises a compelling hypothesis: Could post-weaning shifts in dietary composition, glucose availability, and microbiome status destabilize developmental trajectories in susceptible toddlers?</p><h3>Moving Beyond Ecological Fallacies</h3><p>Asserting that “sugar causes autism” based solely on matching historical trendlines risks an ecological fallacy. For instance, per capita HFCS consumption in the United States peaked around the late 1990s and subsequently declined, while reported ASD rates continued to rise.</p><p>Rather than blaming a single sweetener, we must examine the entire <strong>dietary metabolic environment</strong>. Increased reliance on refined sugars alters pre-pregnancy insulin sensitivity, modifies fetal metabolic programming, and alters early childhood immune function.</p><p>While diets like gluten-free/casein-free (GFCF) or ketogenic protocols show preliminary signals in reducing core ASD symptoms for some children, more targeted prospective studies are needed. Research must move beyond binary diagnostic labels to track maternal glucose variability, toddler nutrient intake, microbiome composition, and inflammatory markers from early pregnancy through the first two years of life.</p><p>Key Takeaways</p><p><strong>Maternal Link:</strong> Diabetes during early pregnancy is consistently tied to a ~25% higher risk of ASD in children due to fetal environmental changes.</p><p><strong>Gut Health:</strong> Fructose alters gut microbiota and barrier integrity rather than driving acute blood sugar spikes, potentially impacting the gut–brain axis.</p><p><strong>Temporal Overlap:</strong> The peak age of autistic regression (~20 months) closely aligns with the rapid transition to a sugar-rich toddler diet.</p><p><strong>Focus on Environment:</strong> ASD risk is driven by complex gene-environment interactions, where the overall metabolic environment plays a crucial supporting role.</p><h4>* This piece was originally published on : <a href="https://drmoonjookim.substack.com/p/why-is-autism-increasing-part-4-could?r=88ythd&amp;utm_campaign=post-expanded-share&amp;utm_medium=web">https://drmoonjookim.substack.com/p/why-is-autism-increasing-part-4-could?r=88ythd&amp;utm_campaign=post-expanded-share&amp;utm_medium=web</a></h4><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=d457bee4b689" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[[NEURODIVERSITY &DEVELOPMENT] What Altered the Human Biological Environment in the Late 19th…]]></title>
            <link>https://medium.com/@itomatokids/neurodiversity-development-what-altered-the-human-biological-environment-in-the-late-19th-7d627099304a?source=rss-0daf706e906c------2</link>
            <guid isPermaLink="false">https://medium.com/p/7d627099304a</guid>
            <category><![CDATA[asperger-syndrome]]></category>
            <category><![CDATA[autism-spectrum-disorder]]></category>
            <category><![CDATA[autism]]></category>
            <category><![CDATA[asperger]]></category>
            <category><![CDATA[aspergers-syndrome]]></category>
            <dc:creator><![CDATA[Dr. Moon-joo Kim]]></dc:creator>
            <pubDate>Fri, 04 Sep 2026 08:03:08 GMT</pubDate>
            <atom:updated>2026-09-04T08:03:08.180Z</atom:updated>
            <content:encoded><![CDATA[<h3>[NEURODIVERSITY &amp;DEVELOPMENT] What Altered the Human Biological Environment in the Late 19th Century?</h3><h4>Why Sugar and Antipyretics Deserve a Closer Look in Autism Spectrum Disorder Research</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*-mdS0-ajH6krqUrELFr_0w.png" /></figure><p>In my previous posts, I highlighted the dramatic rise in the prevalence of Autism Spectrum Disorder (ASD) entering the 20th century. It is biologically improbable that the human DNA sequence itself underwent a sweeping transformation in a span of just a few generations. Therefore, genetics alone cannot fully explain this rapid upward trajectory.</p><p>Ultimately, we must trace the modernization process through the lens of gene-environment interaction and epigenetics — the mechanisms regulating the molecular “switches” of gene expression without altering the underlying DNA sequence.</p><p>Factors such as maternal and infant nutritional status, metabolic conditions, systemic inflammation, pharmaceuticals, and environmental chemicals exert direct influence on these epigenetic processes. What fundamental shifts occurred in the late 19th and early 20th centuries, when humanity’s daily biological environment began to be reshaped?</p><p>Among the many byproducts of modernization, I focus on two crucial variables: <strong>the transformation in dietary refined sugar consumption</strong> and <strong>the widespread emergence of synthetic antipyretic analgesics</strong>.</p><p>The Shift in Dietary Patterns: Disrupting the Maternal Metabolic Environment</p><p>Humanity has a long history with sugar, but it was only after the Industrial Revolution in the late 1800s — with the establishment of mass production and global distribution networks — that the general population began consuming refined sugar on a daily, massive scale. The mechanization of the sugarcane industry and the expansion of international supply chains reshaped culinary culture. Subsequently, the growing availability of refined flour and industrially processed foods gradually shifted dietary patterns away from traditional whole-food diets toward greater consumption of refined carbohydrates and added sugars.</p><p>The question I raise here is not a simple, one-dimensional warning that “sugar is bad for your health.” The core issue is that <strong>the maternal metabolic environment itself may have been restructured compared to historical baselines</strong>.</p><p><em>“An association between maternal diabetes during pregnancy and ASD risk in offspring has been reported across multiple epidemiological studies.”</em></p><p>For instance, a systematic review and meta-analysis published in <em>Medicine</em> (Wan et al., 2018) found that maternal diabetes was associated with an increased risk of ASD in offspring.</p><p>Of course, this does not imply a simple direct causal relationship. However, it supports the view that the maternal metabolic environment experienced by the fetus may be an important factor influencing fetal neurodevelopment. Hyperglycemia, insulin resistance, obesity, and their accompanying chronic inflammation and oxidative stress can alter the placental and fetal microenvironment, potentially influencing neurodevelopmental pathways.</p><p>Dietary patterns can influence the gut microbiome and the production of microbial metabolites. Short-chain fatty acids such as butyrate can modulate histone deacetylase (HDAC) activity, providing one possible biological link between microbial metabolism and epigenetic regulation. Nutrients involved in one-carbon metabolism, including folate and vitamin B12, are also relevant to DNA methylation (Keil &amp;Lein, 2016). These mechanisms provide plausible pathways by which nutritional and metabolic environments may interact with neurodevelopment, representing a biologically plausible pathway worth investigating in relation to ASD.</p><p>Suppressing Infectious Fever with Drugs: Humanity’s New Intervention and the “Fever Effect”</p><p>The second major shift demanding our attention is humanity’s novel practice of pharmacologically suppressing infectious fevers. Paralleling changes in diet, a major transition in healthcare was the explosive adoption of synthetic antipyretic analgesics.</p><p>Fever arising from infection is a vital immune defense mechanism, exquisitely preserved throughout evolutionary history. Elevated body temperature is not a mere physiological byproduct; it represents a sophisticated immune strategy designed to optimize immune cell trafficking and response efficiency. Yet, beginning in the late 19th century, humanity began routinely altering this physiological response with synthetic chemicals. Following the commercial introduction of acetanilide (Antifebrin) in 1886, phenacetin emerged soon afterward, followed in the ensuing decades by aspirin and acetaminophen (Tylenol), which became globally ubiquitous in the 20th century.</p><p>What imprint might the repeated pharmacological suppression of early-life fever leave on neuro-immune interactions during critical developmental windows?</p><p>A critical key deepening this query is the <strong>“Fever Effect”</strong> observed in children with ASD. For decades, parents and clinicians have reported that some children with ASD show temporary behavioral improvements during episodes of fever. A prospective clinical study published in <em>Pediatrics</em> (Curran et al., 2007) documented temporary reductions in irritability, hyperactivity, stereotypy, and inappropriate speech during febrile episodes.</p><p>These observations suggest that physiological changes accompanying fever — such as elevated body temperature, shifts in cytokine signaling, or transient alterations in synaptic function — may transiently influence behavioral expression in at least a subset of individuals with ASD, providing an intriguing clue for neuroimmune research.</p><p><em>Could repeated pharmacological suppression of fever during critical developmental periods influence long-term neuroimmune regulation or epigenetic programming?</em></p><p>A 2024 nation-wide sibling-control study of 2.48 million individuals published in <em>JAMA</em> (Ahlqvist et al., 2024) evaluated maternal acetaminophen use during pregnancy and child ASD risk. Interestingly, the statistical association observed in conventional analyses disappeared when sibling controls were applied. This suggests that associations observed in conventional analyses may be substantially influenced by familial and other unmeasured confounding factors, including the underlying indications for acetaminophen use.</p><p>Hypotheses Requiring Further Investigation</p><p>The concepts presented above remain scientific hypotheses that require rigorous ongoing empirical validation.</p><p>When discussing post-19th-century medical shifts, many quickly point to childhood vaccinations or thimerosal (mercury) compounds. However, large epidemiological studies and meta-analyses have not supported an increased risk of ASD attributable to vaccination or thimerosal exposure. Consequently, I strictly exclude them from this series. Scientific inquiry requires discarding unsupported premises to focus on plausible biological mechanisms.</p><p>The mass consumption of refined sugar and the widespread adoption of chemical antipyretics altered human metabolic environments and immune response pathways starting in the late 1800s. While we cannot conclude that these two factors explain the historical rise in ASD, they represent historical and biological hypotheses that merit careful investigation.</p><p>Moving forward, the questions we must empirically address are clear:</p><p><strong>How might altered sugar metabolism environments post-industrialization affect fetal and infant neurodevelopment through epigenetic modifications?</strong></p><p><strong>What neuro-immunological mechanisms connect fever and immune activation during infections to the “Fever Effect” seen in ASD?</strong></p><p><strong>Does repeated pharmacological suppression of early-life fever influence long-term neuroimmune adaptation or developmental trajectories?</strong></p><p>Over a historical timeframe where our genome remained virtually unchanged, how did our biological environment transform? Pursuing this question is vital as we seek to understand the complex factors influencing Autism Spectrum Disorder.</p><p>In the next post, I will explore how excessive refined sugar intake and artificial fever suppression may interact with neurodevelopmental trajectories and potential spontaneous improvement in ASD, examining the detailed neuro-immunological mechanisms involved.</p><h4>📚 References &amp;Further Reading</h4><p><strong>Wan, H., Zhang, C., Li, H., Luan, S., &amp;Liu, C. (2018).</strong><em>Association of maternal diabetes with autism spectrum disorders in offspring: a systematic review and meta-analysis. </em><strong>Medicine (Baltimore)</strong>, 97(2), e9438. <a href="https://www.google.com/search?q=https://doi.org/10.1097/MD.0000000000009438">https://doi.org/10.1097/MD.0000000000009438</a></p><p><strong>Keil, K. P., &amp;Lein, P. J. (2016).</strong><em>DNA methylation: a mechanism linking environmental chemical exposures to risk of autism spectrum disorders?</em><strong>Environmental Epigenetics</strong>, 2(1), dvv012. <a href="https://www.google.com/search?q=https://doi.org/10.1093/eep/dvv012">https://doi.org/10.1093/eep/dvv012</a></p><p><strong>Curran, L. K., Newschaffer, C. J., Lee, L. C., Crawford, S. O., Johnston, M. V., &amp;Zimmerman, A. W. (2007).</strong><em>Behaviors associated with fever in children with autism spectrum disorders.</em><strong>Pediatrics</strong>, 120(6), e1386–e1392. <a href="https://www.google.com/search?q=https://doi.org/10.1542/peds.2007-0360">https://doi.org/10.1542/peds.2007-0360</a></p><p><strong>Ahlqvist, V. H., Sjöqvist, H., Dalman, C., et al. (2024).</strong><em>Acetaminophen Use During Pregnancy and Children’s Risk of Autism, ADHD, and Intellectual Disability.</em><strong>JAMA</strong>, 331(14), 1205–1214. <a href="https://doi.org/10.1001/jama.2024.3172">https://doi.org/10.1001/jama.2024.3172</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=7d627099304a" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Why Is Autism Increasing? (Part 2)]]></title>
            <link>https://medium.com/@itomatokids/why-is-autism-increasing-part-2-a4b7548a9bbc?source=rss-0daf706e906c------2</link>
            <guid isPermaLink="false">https://medium.com/p/a4b7548a9bbc</guid>
            <category><![CDATA[autism-spectrum-disorder]]></category>
            <category><![CDATA[asperger]]></category>
            <category><![CDATA[autistic]]></category>
            <category><![CDATA[autism]]></category>
            <category><![CDATA[asd]]></category>
            <dc:creator><![CDATA[Dr. Moon-joo Kim]]></dc:creator>
            <pubDate>Mon, 01 Jun 2026 11:33:36 GMT</pubDate>
            <atom:updated>2026-06-01T11:33:36.956Z</atom:updated>
            <content:encoded><![CDATA[<p><strong>Tracking the Historical Inflection Point of Rising Prevalence and Severity</strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/1*Wi9OxWpGbDuJ7-squio4Zg.png" /></figure><p>Today, it is an undeniable reality that the prevalence of Autism Spectrum Disorder (ASD) is continuously rising, and its clinical manifestations are becoming increasingly severe. Understanding the epigenetic factors driving this modern trajectory is one of the most critical research mandates in our quest to discover definitive treatments for ASD. To uncover the root cause, our first step must be to pinpoint the exact historical inflection point where this surge in ASD prevalence and severity actually began. By investigating the environmental shifts that occurred just prior to this critical juncture, we can uncover the definitive clues to why autism is expanding so rapidly.</p><p><strong>Before the 1900s: Symptoms Existed, but the Disease Did Not</strong></p><p>A synthesis of surviving historical records and modern retrospective analyses suggests that prior to the 1900s, ASD in its modern, severe presentation was exceedingly rare, or existed primarily in a relatively mild form. While explicit diagnoses of ASD are absent from European medical literature before the 20th century, we do find clear documentation of individuals who exhibited behaviors highly indicative of the condition.</p><p><strong>The Case of Hugh Blair (1747):</strong> This Scottish court record holds immense retrospective medical value. In a legal proceeding brought to annul a marriage based on the husband’s mental capacity, records detailed that he exhibited highly unstable social communication, impaired social judgment, and prominent “repetitive behaviors”. Modern researchers evaluate this case as a highly probable representation of ASD.</p><p><strong>The Eccentricities of Henry Cavendish:</strong> The 18th-century scientist Henry Cavendish demonstrated extreme social avoidance — minimizing human interaction to an absolute limit — alongside an obsessive, singular focus on his specific fields of research. Reviewing these accounts, the late neurologist Oliver Sacks concluded that it was “highly probable that he was on the autism spectrum”.</p><p><strong>Insights from Eastern Medicine: Xiao’er Yaozheng Zhijue (小兒藥證直訣)</strong></p><p>Similarly, traditional Eastern medical texts contain no records that fully align with modern ASD. Instead, they approached these traits under a different clinical umbrella: pediatric language delay.</p><p>Most notably, the Song Dynasty pediatric text Xiao’er Yaozheng Zhijue explicitly documents nonverbal states and developmental delays, using phrases such as “a child who remains silent for a prolonged period” (兒久不語), “delayed speech” (語遲), and “the inability to speak” (不能言). Modern developmental research confirms that language delay is robustly linked to social developmental delays, and a substantial portion of these historical cases are presumed to have carried underlying autistic traits. What we can infer from these cross-cultural historical fragments is that while individuals with autistic traits certainly existed, their numbers were incredibly small — which explains why autism was never codified as a distinct medical entity. Furthermore, given that these individuals still managed to marry or sustain highly productive careers as scientists, their condition was evidently not severe enough to cause the complete social isolation or profound functional deficits that require full-time external support today. In short, the powerful epigenetic triggers capable of catalyzing an explosive spike and severe presentation of ASD had not yet emerged in the human environment.</p><p><strong>Asperger-like Traits in History’s Greatest Minds</strong></p><p>Modern researchers have frequently retrospectively identified ASD or Asperger-like traits in some of the most influential figures in modern history — most notably, Albert Einstein and Isaac Newton. Their documented biographies provide compelling evidence.</p><p><strong>Albert Einstein:</strong> Einstein famously suffered from a severe language delay, failing to speak in full sentences until he was four or five years old. He also struggled significantly with social relationships, maintained an almost obsessive restriction of interests, and relied heavily on visual rather than verbal thinking. These distinct clinical features led Galina Weinstein to suggest a retrospective diagnosis of Asperger’s Syndrome.</p><p><strong>Isaac Newton:</strong> Renowned psychiatrist Simon Baron-Cohen, along with several other clinicians, has posited that Newton possessed prominent Asperger-like traits. The historical evidence points to his extreme isolation — maintaining virtually no social circle — an obsessive, near-manic immersion in his research, and highly volatile emotional regulation.</p><p>Piecing these historical profiles together confirms a vital thesis: prior to the 1900s, individuals on the spectrum existed only in small numbers and generally remained in a “mild state”. They retained enough social communication and functional capacity to integrate into society, meaning their condition never manifested as a widespread public health crisis.</p><p><strong>The Early 1900s: The Great Inflection Point</strong></p><p>The landscape shifted dramatically at the turn of the 20th century. For the first time in human history, autism transitioned from an individual quirk into an object of systematic medical observation.</p><p><strong>1. 1908 (Theodor Heller, Austria):</strong> Austrian special educator Theodor Heller documented cases of children who, after showing completely normal early development, underwent a rapid and devastating regression around ages 3 to 4, exhibiting autism-like symptoms. This stands as humanity’s very first record of regressive autism, though it was limited to a single subject.</p><p><strong>2. 1925 (Grunya Sukhareva, Ukraine):</strong> Seventeen years later, the first clinical group study emerged. Child psychiatrist Grunya Sukhareva published a detailed medical report tracking six boys who displayed distinct autistic tendencies.</p><p><strong>3. 1943 &amp; 1944 (Leo Kanner &amp; Hans Asperger):</strong> In 1943, American pediatrician Leo Kanner published his landmark paper on 11 children, officially coining and defining the concept of “autistic”. In a striking historical parallel, Austrian pediatrician Hans Asperger published Autistic Psychopathy in Childhood in 1944, detailing his close observations of four young boys.</p><p>As we enter the 20th century, we see these clinical observations suddenly surface, multiply, and mirror each other across both Europe and the American continent. This identical timeline confirms that the early 1900s was the historical inflection point for the emergence of modern ASD. — -</p><p><strong>A Change in Diagnosis, or a True Surge in Severity?</strong></p><p>Skeptics often argue that the rising numbers are merely the result of expanding diagnostic criteria. However, historical data reveals that this period marked not just a rise in numbers, but a profound trend toward worsening severity. In 1971, Leo Kanner published a definitive long-term follow-up study tracking the original 11 autistic children he had first reported on in 1943.</p><p>(Reference: “Follow-up Study of Eleven Autistic Children Originally Reported in 1943,” Journal of Autism and Childhood Schizophrenia)</p><p><strong>The long-term outcomes were devastating:</strong></p><p><strong>Only 2 out of the 11 children</strong> achieved enough functional capacity to live independently.</p><p><strong>The remaining 9 children</strong> languished in states of severe disability, with the vast majority requiring institutionalization in hospitals, specialized facilities, or care homes.</p><p>Kanner’s follow-up proves that we are not looking at a benign shift in administrative definitions. Instead, it signals a genuine, unprecedented biological surge in cases where children completely lost the ability to maintain independent social and cognitive functioning.</p><p><strong>Conclusion: Why We Must Look Closely at the Late 1800s</strong></p><p>Stepping back to look at the macro-historical view, the early 1900s represents a definitive turning point where ASD transformed into a rapidly expanding, severe pathological condition. If this escalation and worsening prognosis are indeed real biological phenomena, we must look past modern diagnostic shifts and rigorously examine the environmental variables that were introduced just prior to this explosion. This directs our scientific gaze squarely at the late 1800s. What radical transformations occurred during this period across Europe and North America regarding <strong>dietary habits (the dawn of industrial food processing and refined sugars) and the medical landscape?</strong> How did these shifts interact with the fragile neuro-immune systems of developing children?</p><p>In my next article, I will dissect the specific environmental and dietary upheavals of the late 1800s, tracing the direct biological mechanisms that tied these historical shifts to the modern autism epidemic.</p><h4>For a more detailed explanation, please visit our English website or read the full article on Substack.</h4><p><strong>🌐 Dr. Tomato Website:</strong><br><a href="https://dr-tomato.com/report/autism-epigenetic-history/">https://dr-tomato.com/report/autism-epigenetic-history/</a></p><p><strong>📖 Substack:</strong><br><a href="https://drmoonjookim.substack.com/p/why-is-autism-increasing-part-2">https://drmoonjookim.substack.com/p/why-is-autism-increasing-part-2</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=a4b7548a9bbc" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[A Long-Term Observational Report of a Case of Regressive Nonverbal Autism Showing Meaningful…]]></title>
            <link>https://medium.com/@itomatokids/a-long-term-observational-report-of-a-case-of-regressive-nonverbal-autism-showing-meaningful-93414d819d80?source=rss-0daf706e906c------2</link>
            <guid isPermaLink="false">https://medium.com/p/93414d819d80</guid>
            <category><![CDATA[autism-treatment]]></category>
            <category><![CDATA[autism-spectrum-disorder]]></category>
            <category><![CDATA[asperger]]></category>
            <category><![CDATA[asd]]></category>
            <category><![CDATA[autism]]></category>
            <dc:creator><![CDATA[Dr. Moon-joo Kim]]></dc:creator>
            <pubDate>Thu, 14 May 2026 06:44:47 GMT</pubDate>
            <atom:updated>2026-05-14T06:44:47.697Z</atom:updated>
            <content:encoded><![CDATA[<h3>A Long-Term Observational Report of a Case of Regressive Nonverbal Autism Showing Meaningful Recovery Following Herbal Treatment Based on GFCFSF Diet and the Dr. Tomato Protocol</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/0*01ywNGZo86ck0wib.jpg" /></figure><h3>Abstract :</h3><p>This case describes the clinical course of a child with regressive nonverbal autism spectrum disorder (ASD) who showed meaningful long-term functional recovery following a treatment combining herbal medicine with the early-stage implementation of a GFCFSF (Gluten Casein Sugar Free) diet as the primary dietary intervention prior to the full establishment of the Dr. Tomato Protocol.</p><p>The Dr. Tomato Protocol is an integrative neuro-immune modulation treatment model that combines dietary and nutritional therapies in a differentiated manner based on symptom severity, centered on herbal medicine. This case can be understood as an early-stage form in which dietary intervention was incorporated.</p><p>There are limitations in establishing causality from a single case. However, the close temporal association between the timing of treatment and functional recovery suggests the possibility that dietary and herbal interventions may have contributed to changes in ASD symptoms through neuro-immune modulation.</p><h4>[Dr. Tomato Protocol]</h4><p>The Dr. Tomato Protocol is an integrative model that views ASD as a condition involving neurodevelopment, immune dysregulation, and potential interactions with infections. It consists of three core components:</p><p><strong>1.Immune modulation (herbal medicine)<br>2.Infection-related considerations<br>3.Dietary and metabolic regulation </strong>This case represents an early-stage application of this framework.</p><h3>1. Patient Profile :</h3><p>Male child born in November 2017 as one of dizygotic twins (male and female)</p><p>Received an opinion suggestive of autism based on evaluation by a clinical psychologist at Yongin Severance Hospital</p><p>Treatment began in May 2020 at 29 months of age</p><h3>2. Developmental History and Main Symptoms :</h3><p>(Based on parental interview prior to treatment)</p><p>· Mother aged 38, father aged 37 at childbirth<br>· Born at 36 weeks and 6 days of gestation, weighing 2.96 kg<br>· At around 3 months of age, social smiling with caregiver was possibleㅋ<br>· At around 6 months, stranger anxiety developed<br>· At around 12 months, used “dad” as a label and showed active interaction with parents<br>· At around 15 months, began independent walking<br>· From 18 to 25 months, used simple words and could engage in back-and-forth interaction, considered normal development<br>· At 26 months, the previously active child became less mobile, appeared fatigued, and remained lying down frequently; at daycare, remained lying down, did not play with peers, and did not interact with teachers<br>· At 27 months, the above symptoms gradually worsened, and atopic dermatitis appeared on the face<br>· After 28 months, crane behavior and pointing disappeared, and language gradually diminished<br>· At 29 months, complete loss of eye contact with parents and regression into a nonverbal autistic state<br>· At 29 months, received an autism-related finding after multiple assessments by a clinical psychologist at Yongin Severance Hospital</p><h3>3. Pre-treatment ATEC Score</h3><p>I. Speech / Language / Communication : 28<br>II. Sociability : 37<br>III. Sensory / Cognitive Awareness : 28<br>IV. Health / Physical / Behavior : 31<br><strong>Total: 124</strong></p><h3>4. Therapeutic Intervention</h3><p>· <strong>Treatment Method :<br></strong>As this case occurred before the completion of the Dr. Tomato Protocol, treatment was conducted using only GFCFSF (Gluten Casein Sugar Free) diet and herbal medicine without nutritional supplementation.</p><p><strong>Treatment Period : Divided into Phase 1, Phase 2, and Phase 3.</strong></p><p>· <strong>Phase 1 : May 2020 — April 2021</strong><br>One-year intensive treatment phase with GFCFSF diet and herbal medicine administered three times daily</p><p>· <strong>Phase 2 : May 2021 — April 2022<br></strong>Although most autistic symptoms had nearly disappeared after Phase 1, treatment was continued with GFCFSF diet and herbal medicine three times daily to prevent relapse</p><p><strong>· Phase 3 : May 2022 — April 2026<br></strong>Herbal treatment discontinued, and dietary intervention gradually relaxed to a normal diet</p><h4>Herbal Prescription :</h4><p>A combination of Jihwang Samul Tang and Gegen Tang was used as the base prescription. To enhance antifungal activity, Gentian, Gardenia, and Akebia were additionally used.</p><p>Xiao Chengqi Tang was added when bowel function was unstable.</p><p>When signs of decreased physical strength appeared, the proportion of tonifying herbs such as Rehmannia, Cinnamon twig, Angelica, and Chuanxiong was increased, while herbs such as Ephedra, Rhubarb, Gardenia, and Akebia that may reduce vitality were decreased, allowing flexible adjustment of the prescription to maintain the child’s immune function as much as possible.</p><p>· Jihwang Samul Tang : Rehmannia 10G, Angelica 5G, Peony 5G, Chuanxiong 5G<br>· Gegen Tang : Pueraria 6G, Cinnamon twig 4G, Peony 4G, Ginger 4G, Jujube 4G, Licorice 2G<br>· Xiao Chengqi Tang : Rhubarb 5G, Immature bitter orange 4G, Magnolia bark 4G</p><h3>5. Changes Over Time and ATEC Results</h3><p>Changes over time based on parental interview</p><p><strong>· Phase 1: </strong>Within 2 days after starting treatment, initial eye contact (brief glances) was observed<br>After 1 month, crane behavior disappeared and pointing began; atopic dermatitis improved; eye contact normalized<br>After 3–4 months, sensory-seeking and stereotyped behaviors disappeared, and aside from language delay, recovery comparable to normal children was observed, including normalization of nonverbal communication<br>After 6–7 months, previously used words before regression began to reappear<br>After combining speech therapy, by around 12 months, interaction using language was normalized</p><p><strong>· Phase 2: </strong>Continued for one year to prevent relapse; after two years of treatment, recovered to normal range with only slightly reduced vocabulary compared to peers</p><p><strong>· Phase 3: </strong>After completion of Phase 2, herbal treatment was discontinued and dietary intervention was gradually relaxed to a normal diet</p><p>Currently attending regular elementary school and performing normal academic activities</p><h4>ATEC Score Progression</h4><p>Before treatment (May 2020)</p><p>I. Speech / Language / Communication : 28<br>II. Sociability : 37<br>III. Sensory / Cognitive Awareness : 28<br>IV. Health / Physical / Behavior : 31<br><strong>Total: 124</strong></p><h4>After completion of Phase 2 (April 2022)</h4><p>I. Speech / Language / Communication : 0<br>II. Sociability : 0<br>III. Sensory / Cognitive Awareness : 4<br>IV. Health / Physical / Behavior : 30<br><strong>Total: 34</strong></p><h4>Current status after Phase 2 (April 2026)</h4><p>I. Speech / Language / Communication : 0<br>II. Sociability : 0<br>III. Sensory / Cognitive Awareness : 1<br>IV. Health / Physical / Behavior : 2<br><strong>Total: 3</strong></p><h3>6. Conclusion and Medical Interpretation</h3><p>This case may be interpreted within the framework of the Dr. Tomato Protocol, particularly in relation to interactions between immune function, dietary factors, and potential infection-related processes.</p><p>However, further studies are required to validate these observations.</p><h4>Patient Analysis :</h4><p>The Dr. Tomato Protocol identifies neurodevelopmental immaturity as the fundamental cause of ASD, consistent with Dr. Goldberg’s neuro-immune hypothesis. From this perspective, the child’s twin birth at 36 weeks and 6 days and low birth weight suggest neurodevelopmental immaturity.</p><p>Twin pregnancies have been reported to increase ASD risk by approximately 1.5–1.7 times, but this is attributed not to twinning itself but to instability associated with maintaining twin pregnancy.</p><p>Twin pregnancies tend to increase premature birth and low birth weight, leading to increased vulnerability in brain development and consequently higher ASD risk. Twins and triplets have shorter gestational periods and higher rates of low birth weight compared to singletons, increasing risks not only for ASD but also ADHD, language delay, motor delay, and intellectual disability.</p><h4>Reference :</h4><p>Within- and between-twin comparisons of risk for childhood behavioral difficulties after preterm birth</p><p>Walking at 15 months indicates motor developmental delay, which is considered an early biomarker of ASD.</p><h4>Reference :</h4><p>Age of First Walking and Associations with Symptom Severity in Children with Suspected or Diagnosed Autism Spectrum Disorder</p><p>Meaning of GFCFSF Diet and Effects and Limitations of Herbal Treatment</p><p>In this case, although severe regression occurred, treatment was initiated early within 3 months after regression, and the child was under 30 months of age, which likely contributed to favorable recovery.</p><p>Dietary intervention was highly significant in this case. Sugar restriction (Sugar-Free) reduces glucose and fructose, which serve as primary energy sources for fungi such as Candida. Increased sugar intake promotes fermentation in the gut, leading to fungal growth. Therefore, sugar restriction plays a critical role in controlling Candida overgrowth.</p><p>Gluten-Free and Casein-Free diets are suggested to support gut barrier function and stabilize immune hyperactivity.</p><p>GFCF diet is one of the most widely studied dietary approaches in ASD. However, within the Dr. Tomato Protocol, its effect is interpreted as being primarily due to reduction in sugar intake rather than solely anti-allergic effects.</p><h4>Reference :</h4><p>Medical approaches to treating Autism Spectrum Disorder and Asperger’s : Dr. Tomato Protocol</p><p>The herbal prescription in this case was based on Jihwang Samul Tang to address skin dryness and decreased vitality. Rehmannia, Angelica, and Chuanxiong are known natural substances with antiviral effects, particularly through enhancing cellular immunity.</p><p>The observation that eye contact improved within 2 days of herbal treatment suggests that herbal medicine may have contributed to stabilizing neuro-immune imbalance.</p><p>Adjustments were made to maintain immune stability, including reducing Ephedra and Rhubarb when fatigue was observed and increasing tonifying herbs.</p><p>The addition of antifungal herbs such as Gentian, Gardenia, and Akebia may have contributed to clinical improvement.</p><p>However, due to variability in herbal formulations, reproducibility and standardization remain major limitations. Developing consistent and effective herbal combinations for severe ASD remains an important challenge.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=93414d819d80" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[What If a Normally Developing Child Suddenly Lost Everything After Age 2?]]></title>
            <link>https://medium.com/@itomatokids/what-if-a-normally-developing-child-suddenly-lost-everything-after-age-2-2f755e74b5ae?source=rss-0daf706e906c------2</link>
            <guid isPermaLink="false">https://medium.com/p/2f755e74b5ae</guid>
            <category><![CDATA[autism]]></category>
            <category><![CDATA[autism-treatment]]></category>
            <category><![CDATA[asd]]></category>
            <category><![CDATA[autism-spectrum-disorder]]></category>
            <category><![CDATA[herbal-medicine]]></category>
            <dc:creator><![CDATA[Dr. Moon-joo Kim]]></dc:creator>
            <pubDate>Wed, 06 May 2026 06:57:31 GMT</pubDate>
            <atom:updated>2026-05-06T10:14:33.982Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*-rs5d24I6qPCerVWr-RhwA.png" /></figure><h4>This article is the first in a planned series of long-term observational reports on autism cases that have shown meaningful recovery following the application of the Dr. Tomato Protocol. Detailed clinical data and extended analysis are available on <a href="https://dr-tomato.com/report/autism-increase-trend/">dr-tomato.com</a> and on <a href="https://drmoonjookim.substack.com/p/a-case-report-of-long-term-observation">Substack.</a></h4><p>This particular case is an observational report of a child with regressive, nonverbal autism spectrum disorder (ASD) who showed meaningful long-term recovery following herbal treatment. It is especially noteworthy because it was conducted before the Dr. Tomato Protocol was fully established, using herbal medicine alone without dietary or nutritional interventions, making it an important early reference point.</p><p>This was not a child who showed developmental problems from the beginning. At around three months of age, social smiling was present, and by twelve months, simple speech had emerged. By eighteen months, the child was using around ten words. In other words, early development was within a relatively normal range.</p><p>However, a significant change began to occur around twenty-four months of age. Eye contact started to diminish, and language began to regress. By twenty-six months, the child had become completely nonverbal, showed no response to surrounding people, and exhibited increasing stereotyped behaviors. This progression closely followed a classic pattern of regressive autism.</p><p><strong>Before treatment, the child’s ATEC scores reflected a severe level of impairment,</strong></p><p><strong>· 28 points in speech,<br>· 35 in sociability,<br>·27 in sensory and cognitive awareness<br>· 19 in health and physical behavior,<br>= resulting in a total score of 109.</strong></p><p>The treatment approach in this case was relatively simple compared to current integrative models. There was no dietary intervention and no use of supplements.<strong> The treatment consisted solely of herbal medicine.</strong></p><p>Following the initiation of herbal treatment, gradual changes began to appear. After approximately one month, eye contact increased noticeably. By three to four months, the child showed a stable response to name and improved interaction with others. Around six months into treatment, language began to re-emerge.</p><p>After one year, although language development was still somewhat behind peers, social interaction with family members had normalized, and most observable autistic features had largely disappeared.</p><p>The changes were also reflected in ATEC scores. The total score decreased from 109 before treatment to 53 after one year, and after approximately ten years of follow-up, measured again in April 2026, the score had further decreased to 13. At present, the child is attending a regular school and functioning within a normal range.</p><h3><strong>How can this case be interpreted?</strong></h3><p>As a single case, it is not possible to establish a definitive causal relationship between treatment and outcome. However, the temporal proximity between the initiation of treatment and the observed improvement is notable and suggests a potential association.</p><p>When interpreted through the perspective of the Dr. Tomato Protocol, this case can be understood differently from conventional models. Rather than viewing autism solely as a disorder of brain development, this framework considers it as a condition that may involve interactions between neurodevelopmental vulnerability, immune system instability, and infection-related processes.</p><p>Within this hypothesis, autism may progress from a state of immature neurodevelopment combined with weakened immune regulation, allowing for opportunistic influences such as viral or fungal factors.</p><p>Looking at the progression of this case, a pattern emerges: relatively normal early development, followed by gradual changes in observational and interactive abilities, and then a rapid regression around the age of two. At this critical point, it becomes reasonable to consider the possible involvement of viral and fungal factors within the broader neuro-immune context.</p><p>From this perspective, the role of herbal medicine may extend beyond simple symptomatic treatment. Herbal intervention may contribute through multiple mechanisms, including immune modulation, antiviral activity, and antifungal effects. These combined actions may have played a role in the observed clinical changes, although this cannot be definitively proven.</p><p>At the same time, important limitations must be acknowledged. This is a single case without a control group, and reproducibility has not been established. Therefore, the findings cannot be generalized.</p><p>Despite these limitations, important questions remain.</p><p>Why do some children show recovery while others do not? Why do certain interventions appear to be effective only at specific developmental stages? These questions remain open.</p><p>This article does not attempt to provide definitive answers. Instead, it is intended to raise questions and to offer a different perspective on how autism may be understood and approached.</p><h4><em>For those interested in the full clinical details, extended analysis, and additional cases, further information is available on </em><a href="https://drmoonjookim.substack.com/p/a-case-report-of-long-term-observation"><em>Substack</em></a><em> and at </em><a href="https://dr-tomato.com/report/autism-increase-trend/"><em>dr-tomato.com</em></a><em>.</em></h4><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=2f755e74b5ae" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Why Is Autism Increasing? Part 1: The Rising Prevalence and the Emergence of ‘Profound Autism’]]></title>
            <link>https://medium.com/@itomatokids/why-is-autism-increasing-part-1-the-rising-prevalence-and-the-emergence-of-profound-autism-1503e87c9f62?source=rss-0daf706e906c------2</link>
            <guid isPermaLink="false">https://medium.com/p/1503e87c9f62</guid>
            <category><![CDATA[asd]]></category>
            <category><![CDATA[autism]]></category>
            <category><![CDATA[autism-spectrum-disorder]]></category>
            <category><![CDATA[profound-autism]]></category>
            <category><![CDATA[drtomato]]></category>
            <dc:creator><![CDATA[Dr. Moon-joo Kim]]></dc:creator>
            <pubDate>Wed, 29 Apr 2026 07:17:55 GMT</pubDate>
            <atom:updated>2026-04-29T07:23:24.804Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*eh-RJ5KT4Xb7Dlmhnf5e3w.png" /></figure><p><strong>Autism Spectrum Disorder</strong> (ASD) is currently recognized as one of the fastest-growing neurodevelopmental disorders in modern society. While debates persist over whether this surge is due to expanded diagnostic criteria or a literal increase in incidence, the data suggests a trend that cannot be ignored.</p><h4><strong>▪️The Statistical Shift : A 20-Year Trajectory</strong></h4><p>According to the <strong>U.S. Centers for Disease Control and Prevention (CDC),</strong> the prevalence of ASD has shown a consistent and steep upward trajectory :</p><p>▪️ Changes in ASD Prevalence (CDC Data)<br>· 2000 : 1 in 150 children<br>· 2010 : 1 in 68 children<br>· 2022 : 1 in 31 children (approx. 3.2%)</p><p>This is not a localized phenomenon. Research by Dr. Young-Shin Kim and colleagues reports a prevalence of approximately 2.6% in South Korea, mirroring trends in the West. ASD is now a global clinical reality.</p><h4>▪️Beyond Numbers : The Rise of “Profound Autism”</h4><p>The shift isn’t just quantitative; the severity of cases is also evolving. <br>The Lancet Commission (2022) has proposed a new clinical category: <strong>“Profound Autism.”</strong> This group, making up about 40% of the ASD population, requires lifelong 24/7 care.</p><p><strong>Major indicators for Profound Autism include : <br></strong>· Intelligence Quotient (IQ) : Below 50<br>· Communication : Non-verbal or very limited language<br>· Functionality : Low social adaptation and increased comorbid seizures or self-injury</p><p>Large-scale studies (2000–2016) show that roughly 26.7% of 8-year-olds with ASD meet these “profound” criteria. This underscores that nearly one-third of the ASD population requires high-level protective care.</p><h4>▪️<strong>The “Trigger” Theory : Gene-Environment Interaction</strong></h4><p>Why is this happening? While diagnostic awareness explains part of the increase, the focus is shifting toward<strong> Gene-Environment Interaction.<br></strong>There is a famous adage in epigenetics:</p><blockquote>“Genetics loads the gun, but the environment pulls the trigger.”</blockquote><p>While genetic predisposition exists, the rapid spike suggests that environmental factors are acting as a catalyst at the epigenetic level.</p><h4>▪️Dr. Tomato Clinical Perspective</h4><p>At the Dr. Tomato Clinical Center, we view ASD not as a static neurological condition, but as a result of <strong>neuro-immune interactions.</strong></p><p><strong>This leads to a pivotal question :<br>✔️ What are the environmental triggers?<br>✔️ Can we achieve recovery by modulating them?</strong></p><p>In the next installment, we will explore the critical windows where “profoundization” occurs and the specific epigenetic drivers behind it.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=1503e87c9f62" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>